ENvue Medical, Inc. 8-K

What Happened

• ENvue Medical, Inc. (FEED) announced on January 30, 2026 that it entered into an Amendment Agreement with the Required Holders of its Series H Convertible Preferred Stock to amend the Certificate of Designations.
• The amendment removes the “Floor Price” provision from the Series H Certificate of Designations in exchange for holders exercising $2,500,000 of their Additional Investment Right. The Company filed the Certificate of Amendment with the Delaware Secretary of State on January 30, 2026 and it became effective upon filing.
• These Series H shares were originally issued in connection with the closing on July 18, 2025 (previously disclosed in the Company’s July 22, 2025 Form 8-K).

Key Details

• Date of Amendment Agreement and filing: January 30, 2026.
• Amount exercised by preferred holders: $2,500,000 of the Additional Investment Right.
• Change implemented: removal of the defined “Floor Price” from the Series H Certificate of Designations.
• Effective: Certificate of Amendment became effective upon filing with the Delaware Secretary of State.

Why It Matters

• This amendment changes the contractual rights attached to the Company’s Series H preferred stock, which can affect how those shares convert or otherwise behave relative to common stock.
• The $2.5M additional investment increases the Company’s committed capital from Series H holders and reflects continued support from those investors.
• Investors should note the alteration of preferred-stock terms (Item 1.01 / Item 3.03 / Item 5.03) as it relates to potential dilution and capitalization; review the filed Amendment Agreement and Certificate of Amendment for full legal details.